Literature DB >> 21394441

Metalloproteinase-1 usefulness in urethral stricture treatment.

Jose Guzmán-Esquivel1, Ivan Delgado-Enciso, Luz M Baltazar-Rodríguez, Alejandrina Rodríguez-Hernández, Ulises Juárez-Pineda, Valery Melnikov.   

Abstract

BACKGROUND: Urethral stricture disease is an obstruction or thinning of the urethra that causes restriction of urinary flow from the bladder during micturition. The object of the present study was to evaluate the effectiveness of the proteolytic enzyme metalloproteinase-1 as treatment in urethral stricture disease.
METHODS: An experimental study was carried out on rabbits in which urethral stricture was created endoscopically by cauterization. The rabbits were divided into three study groups. Metalloproteinase-1 was applied endoscopically in Group 1; phosphate-buffered saline solution was applied in Group 2; and Group 3 was the control group without stricture that received no treatment. The animals were euthanized after 25 days and histopathological slices of the strictured and control regions were stained with Masson's trichrome stain to quantify mean collagen concentration by means of densitometry. Student t test was used to compare the two different groups with parametric variables, and analysis of variance was used to compare more than two groups.
RESULTS: Collagen concentration analysis in the three groups showed a statistically significant difference with P = 0.012 with two degrees of freedom. In the analysis among groups, there was a statistically significant difference that showed the metalloproteinase-1 group had lower collagen concentration than the phosphate-buffered saline group P = 0.009. Urethral opening area in the metalloproteinase-1 group was found to be larger than that in the phosphate-buffered saline group P = 0.048.
CONCLUSIONS: Metalloproteinase-1 protein application in strictured urethral tissue is effective in reducing collagen concentration and maintaining or enlarging urethral opening.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21394441     DOI: 10.1007/s11255-011-9909-x

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  24 in total

Review 1.  Topical use of recombinant human thrombin for operative hemostasis.

Authors:  Christopher D Anderson; Lyndsey J Bowman; William C Chapman
Journal:  Expert Opin Biol Ther       Date:  2009-01       Impact factor: 4.388

2.  Internal urethrotomy in the management of anterior urethral strictures: long-term followup.

Authors:  V Pansadoro; P Emiliozzi
Journal:  J Urol       Date:  1996-07       Impact factor: 7.450

3.  Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor.

Authors:  C Fernandez-Patron; M W Radomski; S T Davidge
Journal:  Circ Res       Date:  1999-11-12       Impact factor: 17.367

Review 4.  Excision and primary anastomosis for anterior urethral stricture.

Authors:  James R Jezior; Steven M Schlossberg
Journal:  Urol Clin North Am       Date:  2002-05       Impact factor: 2.241

5.  In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity.

Authors:  E El Fahime; Y Torrente; N J Caron; M D Bresolin; J P Tremblay
Journal:  Exp Cell Res       Date:  2000-08-01       Impact factor: 3.905

6.  Gene transfer to urethral strictures in rabbits: a preliminary report.

Authors:  P Meria; M Anidjar; J P Brouland; P Teillac; P Berthon; O Cussenot
Journal:  BJU Int       Date:  2000-06       Impact factor: 5.588

Review 7.  PEDF as an emerging therapeutic candidate for osteosarcoma.

Authors:  Crispin R Dass; Eugene T H Ek; Peter F M Choong
Journal:  Curr Cancer Drug Targets       Date:  2008-12       Impact factor: 3.428

8.  Inhibition of collagen synthesis and changes in skin morphology in murine graft-versus-host disease and tight skin mice: effect of halofuginone.

Authors:  F Levi-Schaffer; A Nagler; S Slavin; V Knopov; M Pines
Journal:  J Invest Dermatol       Date:  1996-01       Impact factor: 8.551

9.  Matrix metalloproteinase-1 therapy improves muscle healing.

Authors:  Hany Bedair; T Thomas Liu; Joel L Kaar; Shawn Badlani; Alan J Russell; Yong Li; Johnny Huard
Journal:  J Appl Physiol (1985)       Date:  2007-06

Review 10.  Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives.

Authors:  Jean-Louis Beaudeux; Philippe Giral; Eric Bruckert; Marie-José Foglietti; M John Chapman
Journal:  Clin Chem Lab Med       Date:  2004-02       Impact factor: 3.694

View more
  1 in total

1.  Hyaluronic Acid Reduces Fibrosis in a Rabbit Model of Urethral Anastomosis.

Authors:  Eliseo Portilla-de Buen; Juan Pablo Ramirez-Contreras; Jonathan Matias Chejfec-Ciociano; Rodrigo Lopez-Falcony; David Garcia-Martinez; Jose Gonzalo Vazquez-Camacho; Clotilde Fuentes-Orozco; Francisco Jose Barbosa-Camacho; Juan Carlos Ibarrola-Peña; Alejandro Gonzalez-Ojeda
Journal:  Res Rep Urol       Date:  2021-05-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.